Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2026-01-18 @ 5:09 PM
Study NCT ID:
NCT01719159
Status:
COMPLETED
Last Update Posted:
2016-11-22
First Post:
2012-10-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis
Sponsor:
Anders Svenningsson
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ITT-PMS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER_GOV | View |